Form 8-K - Current report:
SEC Accession No. 0001404644-25-000088
Filing Date
2025-10-09
Accepted
2025-10-09 07:01:21
Documents
50
Period of Report
2025-10-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ngne-20251009.htm   iXBRL 8-K 28145
2 EX-99.1 ngne_prxngn-401updateesgct.htm EX-99.1 23357
3 EX-99.2 a202510_ngnecorporatepre.htm EX-99.2 43427
7 a202510_ngnecorporatepre001.jpg GRAPHIC 104137
8 a202510_ngnecorporatepre002.jpg GRAPHIC 294750
9 a202510_ngnecorporatepre003.jpg GRAPHIC 128549
10 a202510_ngnecorporatepre004.jpg GRAPHIC 59704
11 a202510_ngnecorporatepre005.jpg GRAPHIC 130424
12 a202510_ngnecorporatepre006.jpg GRAPHIC 37907
13 a202510_ngnecorporatepre007.jpg GRAPHIC 120018
14 a202510_ngnecorporatepre008.jpg GRAPHIC 120896
15 a202510_ngnecorporatepre009.jpg GRAPHIC 130005
16 a202510_ngnecorporatepre010.jpg GRAPHIC 35990
17 a202510_ngnecorporatepre011.jpg GRAPHIC 118460
18 a202510_ngnecorporatepre012.jpg GRAPHIC 116097
19 a202510_ngnecorporatepre013.jpg GRAPHIC 128713
20 a202510_ngnecorporatepre014.jpg GRAPHIC 138150
21 a202510_ngnecorporatepre015.jpg GRAPHIC 172348
22 a202510_ngnecorporatepre016.jpg GRAPHIC 128539
23 a202510_ngnecorporatepre017.jpg GRAPHIC 107093
24 a202510_ngnecorporatepre018.jpg GRAPHIC 94131
25 a202510_ngnecorporatepre019.jpg GRAPHIC 122251
26 a202510_ngnecorporatepre020.jpg GRAPHIC 120967
27 a202510_ngnecorporatepre021.jpg GRAPHIC 119239
28 a202510_ngnecorporatepre022.jpg GRAPHIC 76751
29 a202510_ngnecorporatepre023.jpg GRAPHIC 74237
30 a202510_ngnecorporatepre024.jpg GRAPHIC 120575
31 a202510_ngnecorporatepre025.jpg GRAPHIC 101034
32 a202510_ngnecorporatepre026.jpg GRAPHIC 117074
33 a202510_ngnecorporatepre027.jpg GRAPHIC 33822
34 a202510_ngnecorporatepre028.jpg GRAPHIC 92911
35 a202510_ngnecorporatepre029.jpg GRAPHIC 26267
36 a202510_ngnecorporatepre030.jpg GRAPHIC 143302
37 a202510_ngnecorporatepre031.jpg GRAPHIC 134778
38 a202510_ngnecorporatepre032.jpg GRAPHIC 120513
39 a202510_ngnecorporatepre033.jpg GRAPHIC 90307
40 a202510_ngnecorporatepre034.jpg GRAPHIC 90505
41 a202510_ngnecorporatepre035.jpg GRAPHIC 82759
42 image_0.jpg GRAPHIC 6748
  Complete submission text file 0001404644-25-000088.txt   5531075

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngne-20251009.xsd EX-101.SCH 1788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngne-20251009_lab.xml EX-101.LAB 22548
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngne-20251009_pre.xml EX-101.PRE 13050
53 EXTRACTED XBRL INSTANCE DOCUMENT ngne-20251009_htm.xml XML 2802
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

EIN.: 980542593 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 251383595
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)